Skip to content
2000
Volume 17, Issue 15
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Background: Cancer is one of the main causes of death worldwide. Breast cancer is the most prevalent type of cancer in women and the leading cause of cancer deaths due to its high metastasis to the lymph nodes, lungs bones and brain. Interactions with the stromal microenvironment surrounding tumor cells facilitate tumor cell migration and invasion of tissues and dissemination to other organs, to form metastasis. The development of antitumor metal-based drugs was originated with the discovery of cisplatin, however, its severe side effects represent a limitation for its clinical use. Ruthenium (Ru) complexes with different ligands have been successfully studied as promising antitumor drugs. Conclusion: In this review, we focused on the effects of Ru complexes on breast cancer cells and their impact on different steps of the metastatic process.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557517666170206151218
2017-10-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557517666170206151218
Loading

  • Article Type:
    Research Article
Keyword(s): Apoptosis; breast cancer; metastasis; migration; proliferation; ruthenium complexes
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test